Cabaletta Bio, Inc. (CABA)
1.585
+0.06
(+4.28%)
USD |
NASDAQ |
Oct 29, 16:00
1.585
0.00 (0.00%)
After-Hours: 20:00
Cabaletta Bio Market Cap : 265.85M for Oct. 29, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 29, 2026 | 265.85M |
| October 28, 2026 | 254.94M |
| October 27, 2026 | 244.04M |
| October 26, 2026 | 226.43M |
| October 23, 2026 | 246.56M |
| October 22, 2026 | 254.94M |
| October 21, 2026 | 258.30M |
| October 20, 2026 | 270.04M |
| October 19, 2026 | 248.24M |
| October 16, 2026 | 236.49M |
| October 15, 2026 | 259.98M |
| October 14, 2026 | 271.72M |
| October 13, 2026 | 283.46M |
| October 12, 2026 | 300.23M |
| October 09, 2026 | 323.71M |
| October 08, 2026 | 327.07M |
| October 07, 2026 | 330.42M |
| October 06, 2026 | 338.81M |
| October 05, 2026 | 348.87M |
| October 02, 2026 | 335.45M |
| October 01, 2026 | 317.00M |
| September 30, 2026 | 322.03M |
| September 29, 2026 | 332.10M |
| September 28, 2026 | 335.45M |
| September 25, 2026 | 347.19M |
| Date | Value |
|---|---|
| September 24, 2026 | 361.45M |
| September 23, 2026 | 372.35M |
| September 22, 2026 | 419.32M |
| September 21, 2026 | 412.61M |
| September 18, 2026 | 427.70M |
| September 17, 2026 | 432.73M |
| September 16, 2026 | 417.64M |
| September 15, 2026 | 435.25M |
| September 14, 2026 | 488.08M |
| September 11, 2026 | 457.89M |
| September 10, 2026 | 459.57M |
| September 09, 2026 | 488.08M |
| September 08, 2026 | 548.47M |
| September 04, 2026 | 582.01M |
| September 03, 2026 | 583.69M |
| September 02, 2026 | 598.78M |
| September 01, 2026 | 553.50M |
| August 31, 2026 | 521.63M |
| August 28, 2026 | 523.31M |
| August 27, 2026 | 566.92M |
| August 26, 2026 | 545.11M |
| August 25, 2026 | 540.08M |
| August 24, 2026 | 519.95M |
| August 21, 2026 | 524.98M |
| August 20, 2026 | 535.05M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 302.14M |
| Amgen, Inc. | 249.07B |
| Anika Therapeutics, Inc. | 291.62M |
| BioCryst Pharmaceuticals, Inc. | 2.175B |
| Imunon, Inc. | 3.886M |
Market Cap Related Metrics
| Price to Book Value | 1.262 |
| Price | 1.585 |
| Earnings Yield | -99.80% |